http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2233672-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295 |
| filingDate | 2003-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b06bdbe88823b7913736e3db233cfbc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7b64dc763eae50257b32adbab155278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_903bdfcf3867f38151bc1044c1b41e0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fa0b80e4657175d82116864454e0f35 |
| publicationDate | 2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2233672-C1 |
| titleOfInvention | Mixed vaccine for immunoprophylaxis of viral hepatitis b and d, tetanus and diphtheria |
| abstract | FIELD: biotechnology, medicine, vaccines. n SUBSTANCE: invention relates to a mixed vaccine comprising some antigens in a single preparation. New mixed vaccine comprises the following components: hepatitis B virus surface antigen (HBsAg/ayw) prepared by culturing the yeast strain Pichia angusta VKM Y-2924 D and/or hepatitis B virus surface antigen (HBsAg/adw) prepared by culturing the yeast strain H. polymorpha VKPM Y-2412 in the amount 5-10 mcg; diphtheria anatoxin, 5-10 Lf; tetanus anatoxin, 5-7.5 EC; aluminum hydroxide (Al 3+ ) gel, 0.35-0.55 mg; merthiolate, 15-35 mcg, and 0.9% NaCl, up to 0.5 ml. Hepatitis B virus antigens (HBsAg/ayw) and (HBsAg/adw) are taken in vaccine in the ratio = 1:1. The novel mixed vaccine is high-immune, nontoxic preparation providing carry out immunization against pathogens of some diseases of viral and bacterial etiology. The application of invention provides expanding assortment of agents designated for simultaneous prophylaxis of viral hepatitis B and D, tetanus and diphtheria. n EFFECT: valuable medicinal properties of mixed vaccine. n 2 cl, 10 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005023297-A1 |
| priorityDate | 2003-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.